Described herein are gene-activated fibrillar compositions and methods, processes, devices for the design, preparation, manufacture and/or formulation of thereof which are capable to encode at least one polypeptide of interest. Methods treating a disease, disorder and/or condition in a subject by increasing the level of at least one polypeptide of interest, by administering to said subject the gene-activated fibrillar composition are also disclosed.
